OPKO Health, Inc. Share-based Payment Arrangement, Expense
OPKO Health, Inc. (OPK) reported Share-based Payment Arrangement, Expense of $10.70 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-02-26
- OPKO Health, Inc. share-based payment arrangement, expense for the quarter ending 2022-12-31 was $3.20M, a 13.51% decline year-over-year.
- OPKO Health, Inc. share-based payment arrangement, expense for the quarter ending 2022-09-30 was $3.40M, a 10.53% decline year-over-year.
- OPKO Health, Inc. share-based payment arrangement, expense for the quarter ending 2022-06-30 was $4.30M, a 22.86% increase year-over-year.
- OPKO Health, Inc. share-based payment arrangement, expense for the quarter ending 2022-03-31 was $7.60M, a 192.31% increase year-over-year.
- OPKO Health, Inc. share-based payment arrangement, expense for fiscal 2025 was $10.70M, a 2.73% decline from fiscal 2024.
- OPKO Health, Inc. share-based payment arrangement, expense for fiscal 2024 was $11.00M, a 3.51% decline from fiscal 2023.
- OPKO Health, Inc. share-based payment arrangement, expense for fiscal 2023 was $11.40M, a 38.38% decline from fiscal 2022.
- OPKO Health, Inc. share-based payment arrangement, expense for fiscal 2022 was $18.50M, a 36.03% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2025-12-31 | $10.70M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $11.00M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $11.40M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $6.60M derived: sum of 2 quarters · filed 2025-03-03 | $10.90M derived: sum of 3 quarters · filed 2025-03-03 | $18.50M 10-K · filed 2025-03-03 |
| 2022-09-30 | $3.40M 10-Q · filed 2022-11-08 | $7.70M derived: sum of 2 quarters · filed 2022-11-08 | $15.30M 10-Q · filed 2022-11-08 | $19.00M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $4.30M 10-Q · filed 2022-08-04 | $11.90M 10-Q · filed 2022-08-04 | $15.60M derived: sum of 3 quarters · filed 2024-03-01 | $19.40M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | $7.60M 10-Q · filed 2022-05-09 | $11.30M derived: sum of 2 quarters · filed 2024-03-01 | $15.10M derived: sum of 3 quarters · filed 2024-03-01 | $18.60M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $7.50M derived: sum of 2 quarters · filed 2024-03-01 | $11.00M derived: sum of 3 quarters · filed 2024-03-01 | $13.60M 10-K · filed 2024-03-01 |
| 2021-09-30 | $3.80M 10-Q · filed 2022-11-08 | $7.30M derived: sum of 2 quarters · filed 2022-11-08 | $9.90M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $3.50M 10-Q · filed 2022-08-04 | $6.10M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $2.60M 10-Q · filed 2022-05-09 | |||
| 2020-09-30 | $2.70M 10-Q · filed 2021-10-28 | $4.30M derived: sum of 2 quarters · filed 2021-10-28 | $6.80M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $1.60M 10-Q · filed 2021-07-29 | $4.00M 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $2.50M 10-Q · filed 2021-04-28 | |||
| 2019-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $6.50M derived: sum of 2 quarters · filed 2020-10-29 | $11.00M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $7.60M 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $4.50M 10-Q · filed 2020-05-06 | |||
| 2018-09-30 | $5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $10.70M derived: sum of 2 quarters · filed 2019-11-05 | $16.60M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $5.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $11.50M 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $5.90M 10-Q · filed 2019-05-08 | |||
| 2017-09-30 | $6.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $12.60M derived: sum of 2 quarters · filed 2018-11-09 | $22.30M 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $15.80M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $9.70M 10-Q · filed 2018-05-08 | |||
| 2016-09-30 | $34.90M 10-Q · filed 2017-11-08 | |||
| 2013-06-30 | $1.80M 10-Q · filed 2013-08-09 | $7.00M 10-Q · filed 2013-08-09 | $8.80M derived: sum of 3 quarters · filed 2013-08-09 | $9.90M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $5.20M 10-Q · filed 2013-05-10 | $7.00M derived: sum of 2 quarters · filed 2013-05-10 | $8.10M derived: sum of 3 quarters · filed 2013-05-10 | $9.10M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $2.90M derived: sum of 2 quarters · filed 2013-03-18 | $3.90M derived: sum of 3 quarters · filed 2013-08-09 | $5.10M 10-K · filed 2013-03-18 |
| 2012-09-30 | $1.10M 10-Q · filed 2012-11-09 | $2.10M derived: sum of 2 quarters · filed 2013-08-09 | $3.30M 10-Q · filed 2012-11-09 | $4.90M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $1.00M 10-Q · filed 2013-08-09 | $2.20M 10-Q · filed 2013-08-09 | $3.80M derived: sum of 3 quarters · filed 2013-08-09 | $5.60M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $1.20M 10-Q · filed 2013-05-10 | $2.80M derived: sum of 2 quarters · filed 2013-05-10 | $4.60M derived: sum of 3 quarters · filed 2013-05-10 | $6.50M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $3.40M derived: sum of 2 quarters · filed 2013-03-18 | $5.30M derived: sum of 3 quarters · filed 2013-03-18 | $7.00M 10-K · filed 2013-03-18 |
| 2011-09-30 | $1.80M 10-Q · filed 2012-11-09 | $3.70M derived: sum of 2 quarters · filed 2012-11-09 | $5.40M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | $1.90M 10-Q · filed 2012-08-09 | $3.60M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $6.50M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |